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Tamm-Horsfall glycoprotein binds IgG with high affinity. Tamm-
Horsfall protein (THP), a monomeric glycoprotein (Mr 80 to 100 kDa),
is produced by the mammalian kidney's thick ascending limb of Henle
cells and excreted into the urine. The function of THP is uncertain.
Here we report that a high molecular weight contaminant in sheep THP
(sTHP) preparations was identified as sheep IgG by its positive reaction
with donkey anti-sheep IgG antibody and with protein G. To answer the
question of whether sTHP and sheep IgG co-purified because of a
physical interaction between the two proteins, an enzyme-linked im-
munosorbent assay (ELISA) using immobilized sTHP and soluble
sheep IgG was performed. Analysis of the ELISA data identified the
presence of two sets of binding sites: a high affinity site (Kd 102 to
iO M) and a lower affinity site (Kd 10— 10 to 10" M). The ELISA
detected a similar high affinity interaction between human THP (hTHP)
and human IgG. The binding of sheep IgG to immobilized sTHP was
inhibited by soluble sTHP. These observations suggest an additional
factor to be considered in studies addressing THP's potential immuno-
regulatory function.
In 1950, Igor Tamm nd Frank Horsfall isolated, by salt
precipitation, a protein from human urine that inhibited hem-
agglutination by various viruses [1]. Over the last 40 years
studies have elucidated many of the biochemical, physiological,
and pathological properties of this protein, termed THP.
THP has an approximate molecular weight of 80 to 100 kDa
[2—4] with roughly 28% of its mass being contributed by
N-linked carbohydrates [5]. The primary amino acid sequence
of human THP (hTHP) has been determined [6, 7] and shown to
be identical to "uromodulin," an immunosuppressive protein
originally purified from the urine of pregnant women [4]. The
sole site of THP production is in the cells lining the thick
ascending limb of Henie in the mammalian kidney [8]. Rindler
et a! [9] determined that THP was a glycosylphosphatidyl
inositol-linked membrane protein for at least a portion of its life.
However, large quantities of THP (20 to 200 mg) are excreted
daily into human urine [10].
While the normal function of THP remains uncertain, THP
has been hypothesized to be important in urine concentration
[11, 12], immunoregulation, and as a host defense mechanism
against bacterial urinary tract infections. Some of the potential
immunoregulatory actions of THP involve the ability of THP to
bind the cytokines IL-i [13], IL-2 [14], and TNF [15]. Addition-
ally, THP inhibited lymphocyte proliferation induced by anti-
gen [4], IL-i [16], and leucoagglutinin [17, 18] in vitro. Con-
versely, THP added to peripheral blood lymphocytes (PBL) in
culture appeared to stimulate blastoid transformation [19, 20].
The potential role of THP as a host defense mechanism was
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suggested by the observation that E. coli exhibiting type 1 pii
were bound and trapped by THP [21]. At concentrations of 100
/LgIml or more, THP greatly decreased adherence of type 1
fimbriated E. coli to cultured uroepithelial cells [22]. Addition-
ally, THP stimulated polymorphonuclear leukocytes (PMN)
under some conditions [23, 24].
The long-term goal of the current study was to elucidate the
role of THP in the pathophysiology of E. coli-induced pyelone-
phritis, using sheep as the experimental model. Early in this
project, however, samples of sheep THP (sTHP) were found to
be contaminated with a protein which was subsequently shown
to be sheep IgG by its reaction with donkey anti-sheep IgG
antiserum and with protein U. To determine whether sTHP and
sheep LgG simply co-purified because of similar chemical be-
haviors or whether they actually interacted with each other,
subsequent studies utilized an enzyme-linked immunosorbent
assay (ELISA) to quantify the binding between these two
molecules. A comparable ELISA was used to test binding of
human THP (hTHP) with human IgG.
Methods
Isolation of THP
Initial experiments were performed with THP isolated from
the urine of a single, clinically healthy, adult Suffolk ewe (E-1).
Subsequently, two mixed-breed adult ewes (E-2 and E-3) and
two mixed breed wethers (W-l and W-2), initially six to seven
months old, were purchased. These sheep were healthy as
assessed by physical examination, complete blood counts,
serum chemistry profiles, and urinalyses.
Urine was collected from individual sheep by placing them in
a raised, head-catch stanchion for 16 to 24 hours with access to
food and water. Urine passed through a heavy gauge metal
screen and then through a finer metal screen before being
funneled by a plastic lined, slanted pan into a plastic bucket
immersed in ice. Urine was removed from the bucket multiple
times during the collection period and filtered through glass
wool. Sodium azide, approximately 10 mg/liter, was added to
the urine before storing the urine at 4°C.
Once the collection was completed, 0.58 mol NaCI/liter was
dissolved in the urine [1]. After storing the urine at 4°C
overnight, it was centrifuged at 13,900 x g for 75 minutes at
4°C. Pellets were resuspended in water and dialyzed against 6
liters water at 4°C overnight. After dialysis, an equal volume of
8 M urea was added to the sTHP-enriched solution and allowed
to incubate at 4°C overnight to help solubilize the precipitated
sTHP. This 4 M urea solution was ultracentrifuged at 85,000 x
g at 4°C for 40 minutes. The supernatants were dialyzed
extensively against water at 4°C, and then 4 M NaCl was added
to this dialyzed sample to make the solution 0.58 M NaC1. The
next day the pellets obtained by centrifugation at 85,000 x g
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were resuspended and dialyzed in water, before being frozen at
—70°C either for future lyophilization or long-term storage.
hTHP was isolated from a pooled, 24-hour urine sample from
two adult males. The techniques used were identical to those
employed with sheep urine except no sodium azide was added
to the urine during its storage at 4°C. Cat THP (cTHP) analyzed
in these experiments was obtained from pooled urine samples
from three castrated male cats as described previously [25].
Electrophoresis and Western blotting techniques
THP isolation from urine was monitored using discontinuous
7.5% SDS polyacrylamide gel electrophoresis (SDS-PAGE)
[26]. The molecular weight standards were reduced with f3-mer-
captoethanol, while the other gel samples were non-reduced.
Subsequently, to assess the effect of disulfide bond reduction on
the sTHP samples, SDS-PAGE using a 5% to 15% gradient was
utilized to analyze non-reduced and reduced sTHP and sheep
IgG. All gels were stained with silver nitrate [27] after fixation
overnight in 50% methanol and 1.5% glutaraldehyde.
Western blot analyses characterized the sTHP isolate further.
In the first blot, proteins from cat urine, cTHP, sTHP, and
hTHP were separated by 7.5% SDS-PAGE and transferred
electrophoretically to 0.45 m nitrocellulose (NC) (Gelman,
Ann Arbor, Michigan, USA) [28]. After incubating the resulting
NC with 5% non-fat dry milk in TBS (50 mrs Tris/lSO mM NaCI,
pH 7.4), one of the NC strips was incubated with affinity
purified sheep anti-cTHP antiserum [25] diluted with 5% milk in
TBS/0. 1% Tween 20 (TBS-T) overnight, as part of a related
study. Another NC strip was incubated with donkey anti-sheep
IgG conjugated to horseradish peroxidase (HRP) (Sigma Chem-
ical Company, St. Louis, Missouri, USA). The sheep anti-
cTHP incubated blot was rinsed with TBS-T and then incubated
for three hours with donkey anti-sheep IgG-HRP. Both strips
were developed using 4-chloro-l-napthol.
In another experiment, electrophoresed samples of sheep
serum, sheep IgG, and sTHP were transferred to NC. After
blocking the NC with 3% gelatin in TBS, protein G-HRP
(Bio-Rad, Richmond, California, USA) in 1% gelatin/TBS-T
was incubated with the strips. As a control, a NC strip was
incubated overnight in the same protein G-HRP solution with
the addition of 2 mg of sheep IgG (Sigma Chemical Company)..
Bound protein G-HRP was detected with 4-chloro-i-napthol.
THP/IgG ELISA
Lyophilized sTHP and sheep IgG (Sigma Chemical Com-
pany) were dissolved in 0.05 M sodium carbonate buffer (pH
9.6). Samples were centrifuged for 10 minutes at 13,600 x g
(4°C). The protein concentrations in the supernatants were
determined spectrophotometrically [29]. Microtiter assay plates
(Falcon Pro-Bind Assay Plate, Becton Dickinson, Lincoln
Park, New Jersey, USA) were coated with 50 j.d/well of 30
pg/ml sTHP. Similarly, wells to be used in converting the 0D410
of test wells to "pu sheep IgG bound" were coated with 0.1 to
2.0 g/ml sheep IgG. The plates were incubated at 4°C over-
night with shaking. The next day, the plates were rinsed with
0.05 M sodium carbonate buffer (pH 9.6), before 150 d of 1%
bovine serum albumin (Calbiochem, LaJolla, California, USA)
in 0.05 M sodium carbonate (pH 9.6) was added to all wells.
After another overnight incubation, plates were rinsed with 19.8
mM Tris/20 mrt NaC1/2.7 mri KC1/0.05% Tween 20 (pH 7.4)
(Tris IgG assay buffer) and stored at —20°C.
The standard sTHP/sheep IgG ELISA was performed as
follows. Sheep IgG was dissolved in Tris IgG assay buffer.
Insoluble material was removed by centrifugation at 13,600 X g
for 10 minutes at 4°C. The protein concentration of the super-
natant was determined using the 0D280 and an extinction
coefficient of 13.6 [29]. Serial dilutions of sheep IgG were made
in 1% albumin/Tris IgG assay buffer. There typically were
twelve different sheep IgG dilutions ranging from 3 mglml to I
sg/ml for each assay. Microtiter plates, previously coated with
sTHP, were loaded with 50 jd of the various sIgG dilutions in
triplicate wells and incubated overnight at 4°C. Mter rinsing
plates in Tris IgG assay buffer, 50 d rabbit anti-sheep IgG-
alkaline phosphatase (Pel-Freez, Rogers, Arkansas, USA),
diluted in 1% albuminlTris IgG assay buffer, was incubated in
wells at 37°C for two hours. Unbound enz jme-labeled antibody
was pipetted from the wells and plates were washed, first with
Tris IgG assay buffer, and then with 0.05 M sodium carbonate
buffer (pH 9.6). The developing solution (4 mrvi p-nitrophenol
phosphate/i m MgC12/0.05 M sodium carbonate buffer, pH
9.6), was added to all wells (100 .dJwell) and the reaction
proceeded at room temperature until the 0D410 of the highest
sIgG concentration wells reached approximately 2.3 (about 20
mm). The reaction was stopped with 25 d of 2 N NaOH/well.
The absorbance of each well at 410 nm was measured with a
manual microtiter plate reader (Dynatech, Chantilly, Virginia,
USA). At least two sTHP samples from each of the five sheep
were assayed.
Variations in this standard assay included competition exper-
iments where the ability of soluble sTHP (30 jsg/ml) to inhibit
the binding of sheep IgG to sTHP coated plates was examined.
Additionally, the ability of hTHP to bind human IgG (Sigma
Chemical Co.) was tested using procedures analogous to sTHP
binding studies.
Each ELISA plate had control wells, including wells coated
with THP and incubated with the enzyme-conjugated anti-IgG
antibody to detect background reactions. When the absorbance
in these wells was above the usual background levels (0D410
0.060), this absorbance was subtracted from the 0D410 of each
well where IgG had been added. This was only necessary with
THP from sheep E-i. Additionally, some wells were not coated
with THP, but were blocked with albumin prior to incubation
with 3 mg/mi IgG and the enzyme-conjugated anti-IgG. Higher
than normal background readings were present only in the
hTHP/human IgG assay. Thus, for each human IgG concentra-
tion, three wells coated with hTHP and three wells not coated
with THP were analyzed and the 0D410 from "no hTHP wells"
were subtracted from the corresponding absorbances of the
hTHP coated wells.
Data analysis
For analysis of the THP/IgG ELISA binding data, the absor-
bance readings of the IgG coated wells that yielded values in the
middle portion of the absorbance range were divided by the
picomoles of IgG loaded into the wells. If more than one IgG
concentration was utilized, this factor was averaged and then
used to convert the absorbance readings in the THP coated
wells into "pmoles of IgG bound". For the wells coated with
THP, the [free IgG] was calculated using the equation:
[free IgG] = [total IgG] — [bound IgG], where [total IgG] was
the amount initially added to these wells. Scatchard plots [30]
were drawn by plotting [bound IgG]/[free IgG] versus [bound
IgG]. The affinity constants were determined using a non-linear
least squares computer program (MINSQ, MicroMath Scien-
tific Software, Salt Lake City, Utah, USA) and the following
equations:
A1One-site model: A =
1 + (Kcn/x)
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Fig. 1. A. Steps in pur(fication of sTHP from sheep urine analyzed by silver-stained 7.5% SDS-PAGE. Except for the molecular weight standards
(/3-spectrin, /3-galactosidase, phosphorylase B, bovine serum albumin, and ovalbumin) which were reduced with 2% /3-mercaptoethanol, the gel
samples were not reduced. Approximate protein concentrations loaded in each well were determined by either dry weight measurements or
Coomassie Brilliant Blue 0-250 assays [33]. Lane A: sheep urine (3 pg protein); Lane B: supernatant from first centrifugation (3 pg protein); Lane
C: pellet from first centrifugation (6 pg protein); Lane D: 4 si urea pellet (6 pg protein); Lane E: 4 M urea supernatant (6 pg protein); Lane F:
supernatant after 0.58 Sf NaC1 addition (6 pg protein); Lane G: final pellet after 0.58 M NaCI precipitation (10 pg protein). Solid arrow indicates
negatively staining sTHP band. Open arrow indicates high molecular weight contaminating protein. B. Serial dilutions of the 10 pg of protein in
lane G assessed by silver-stained 7.5% SDS-PAGE. All sTHP samples were non-reduced.
A1 A2Two-site model: A = +
1 + (K1/x) 1 + (Kd2Ix)
where A = total [bound IgG], x = [free IgG], Kdi and Kd2 are
the dissociation constants for the two binding sites, and A1 and
A2 are the concentrations of each binding site [31]. The F-ratio
test was used to determine if the two-site model predicted
parameters significantly better (P < 0.05) than the one-site
model [32].
Results
sTHP isolation
As illustrated in Figure 1, sTHP was purified progressively
from whole urine (Lane A) where sTHP was a minor compo-
nent, to the final stage (Lane G) where sTHP was the major
component, staining negatively with a molecular weight of
approximately 90 kDa. Besides sTHP in this final preparation
the primary contaminating proteins were seen as a discrete dark
band of approximately 200 kDa and two more diffuse bands (Mr
62 kDa and 43 kDa). By serially diluting the sTHP sample (Fig.
1B), it was estimated that each contaminating band represented
less than 2% of the total protein in the final precipitant.
Identity of the 200 kDa contaminating protein
While the identity of the upper molecular weight contaminat-
ing protein in these non-reducing gels initially was unknown,
three sets of experiments demonstrated that this protein was
sheep IgG. First, in a Western blot where the reactivity of sheep
anti-cTHP antibody was tested against cTHP, sTHP, and hTHP
(Fig. 2), this antibody appeared to strongly recognize not only
cTHP, but also the 200 kDa protein in the sTHP sample (panel
B). However, in the negative control (panel C) where the NC
was reacted only with HRP-conjugated donkey anti-sheep IgG
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Fig. 2. Western blot demonstrating reaction of upper molecular weight contaminating protein with anti-sheep IgG antiserum. THP samples were
non-reduced, while pre-stained molecular weight standards (a2-macroglobulin, J3-galactosidase, fructose-6-phosphate kinase, pyruvate kinase, and
fumarase) were reduced. A Stained with amido black; B Reacted with sheep anti-cTHP serum and HRP-conjugated donkey anti-sheep IgG; C
Reacted with HRP-conjugated donkey anti-sheep lgG only. Lane 1: dialyzed cat urine, Lane 2: cTHP final pellet; Lane 3: sTHP final pellet; Lane
4: hTHP final pellet. The solid arrow marks the upper molecular weight contaminating protein band.
antiserum, the upper molecular weight contaminant in the
sTHP sample reacted strongly, suggesting that this protein was
sheep IgG.
Subsequently, Western blots of sheep serum, sheep IgG, and
sTHP were reacted with protein G. In all three of these samples
(Fig. 3B), a band with the same electrophoretic mobility bound
protein G-HRP. An identical NC strip was incubated with
protein G-HRP and sheep IgG simultaneously as a negative
control. As shown in Figure 3C, soluble sheep IgG did inhibit
the reaction of protein G with bound IgG, however, the sTHP
band showed a positive reaction under these conditions.
As a final confirmation of the 200 kDa protein's identity,
purified sheep IgG and sTHP were analyzed simultaneously by
gradient SDS-PAGE in both non-reduced and reduced states
(Fig. 4). Non-reduced purified sheep IgG and the sheep IgG in
the sTHP sample migrated similarly with an approximate mo-
lecular weight of 173 kDa. When the disulfide bonds in sheep
IgG were reduced, major bands migrating at 62, 53, and 27 kDa
were observed (lane 3). Similar bands were present in the sTHP
reduced sample (lane 4).
THP/IgG binding assays
sTHP from the three ewes and two wethers were assayed for
their ability to bind sheep IgG using an ELISA. sTHP from all
five sheep bound sIgG in a dose dependent manner as illustrated
by the data from E-2 in Figure 5. Transformation of the
sTHP/sheep IgG binding data into a Scatchard plot resulted in
graphs similar to the one shown in Figure 6 for all sheep. These
curved Scatchard plots suggested that binding was occurring at
sites with two distinct binding affinities [34, 351. These binding
affinities were estimated for two sTHP samples from each
animal. The Kd of the high affinity sites ranged from 10—13 M to
1012 M, while the low affinity site Kd was approximately 10
to 10b0 M for all samples. The F-ratio test showed that the two
binding site model predicted the binding parameters signifi-
cantly better than the one binding site model (P < 0.05).
Using a comparable ELISA, hTHP bound human IgG in a
dose dependent manner. As in the sTHP studies, hTHP/human
IgG binding data were best described by a two binding site
model. The predicted Kd for the high and low affinity binding
sites were approximately 10 12 M and l0 10 M, respectively.
To determine whether IgG was binding to THP at sites only
exposed when THP molecules were bound to the solid phase,
the ability of soluble sTHP to inhibit sIgG binding to immobi-
lized sTHP was examined. As illustrated in Figure 7, soluble
sTHP markedly inhibited sheep IgG binding to immobilized
sTHP.
Discussion
The estimate of the molecular weight of non-reduced sTHP
(90 kDa) predicted by SDS-PAGE was similar to the molecular
weight of non-reduced hTHP previously reported [36—38]. In
gels such as Figure 1A that were overloaded with THP (approx-
imately 10 g) in order to detect contaminants, THP migrated
as a diffuse band that stained darker at its edges than in its
"negatively" stained central region. This negatively stained
center on heavily loaded gels has been noted with other
silver-stained proteins and attributed to variability in the way
different proteins react with silver stain [39, 40]. On gels where
the sTHP protein concentration gradually was decreased (Fig.
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Fig. 3. Western blot comparing the reaction of protein G with sheep serum (Lane 1), sheep IgG (Lane 2) and sTHP final pellet (Lane 3). Except
for the molecular weight standards which were the same as in Fig. 2, the protein samples were not reduced with /3-mercaptoethanol. A. Stained
with amido black. B. Incubated with protein G-HRP. C. Incubated with protein G-HRP and soluble sheep IgG. Arrowhead indicates positively
IB), the two densely stained borders and the negatively stained
center of the sTHP band coalesced into a single band, with a
mobility equal to the central region of the originally negatively
stained band. This confirmed that only one protein was repre-
sented by the original broad band.
The identity of the two primary low molecular weight con-
taminating bands (62 kDa and 43 kDa) in the sTHP samples seen
with 7.5% SDS-PAGE is uncertain. However, they may repre-
sent degradation products of sTHP since they migrate as diffuse
bands typical of glycoproteins and since two glycoproteins with
molecular weights of 66 kDa and 51 kDa were produced when
calf THP was degraded partially by mild acid hydrolysis [41].
The identity of the higher molecular weight contaminating
band in the sTHP samples as sheep IgG first was suspected
when this protein reacted positively with donkey anti-sheep
IgG-HRP (Fig. 2). The use of protein G not only helped confirm
that this protein was sheep IgG, but also provided insight into
the binding site of THP for IgG. The ability of sTHP to react
positively to protein G-HRP when soluble sheep IgG was
present (Fig. 3C) suggested that electrophoretically transferred
sTHP was capable of binding soluble sheep IgG and that sTHP
and protein G-HRP recognized different sites on sheep IgG.
Additional evidence that IgG was present in the sTHP sample
was gathered from the gradient acrylamide gel. The high
molecular weight protein migrated identically to sheep IgG in
non-reduced samples, while similar bands representing the IgG
heavy and light chains were present in both the sheep IgG and
sTHP samples after disulfide bond reduction (Fig. 4). The
predicted molecular weight of sheep IgG was 200 kDa in the
7.5% gels and 173 kDa in the 5 to 15% gels rather than the
published value for IgG of 150 kDa [421 possibly because the
SDS-PAGE molecular weight standards had disulfide bonds
reduced, and thus more SDS/g of protein could bind these
proteins than could bind the non-reduced IgG. In the reduced
IgG sample, the heavy chain appeared as a doublet. This has
been noted by others and attributed to heterogeneity in IgG's
oligosaccharide moieties [43].
Previous researchers occasionally have noted an upper mo-
lecular weight band in hTHP preparations, but suggested that it
represented a THP dimer [20, 44]. While IgG has not been
identified previously in THP preparations, Muchmore and
Decker [4], in their initial report on the isolation of uromodulin
(THP isolated from pregnant women), noted that antibodies
against uromodulin raised in rabbits appeared to recognize
weakly an "area consistent with human IgG" in human sera by
Western blot analysis, suggesting that the uromodulin (THP)
used as the immunogen might have contained a small amount of
human IgG.
Once the high molecular weight protein in the sTHP sample
from E-l was identified as sheep IgG, the question arose as to
whether sTHP and sheep IgG bound each other. This was
answered positively with the ELISA which demonstrated dose
dependant binding between immobilized sTHP and soluble
sheep IgG (Fig. 5). Scatchard plots from the sTHP/sheep IgG
binding data produced non-linear curves (Fig. 6) indicative of
reactions having more than one affinity constant. This can occur
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Fig. 4. Silver-stained 5% to 15% SDS-PAGE comparing the electro-
phoretic mobility of purified sheep IgG to the sheep IgG in the sTHP
sample in non-reduced and reduced states. Lane 1: non-reduced sheep
IgG; Lane 2: non-reduced sTHP (curved arrow indicates non-reduced
sheep IgG); Lane 3: sheep IgG reduced with /3-mercaptoethanol; Lane
4: sTHP reduced with /3-mercaptoethanol (open arrow indicates IgG
heavy chains and closed arrow indicates light chains). Molecular weight
standards included myosin, /3-galactosidase, bovine serum albumin,
ovalbumin, carbonic anhydrase, and soybean trypsin inhibitor.
either when there are multiple binding sites with different and
fixed affinities or when multiple binding sites exist that initially
have the same affinity, but once ligand binds to one site, the
affinity for ligand decreases at the unoccupied sites (negative
cooperativity) [45]. Without further thermodynamic or struc-
tural data, the difference between these scenarios cannot be
determined; however, the prediction of the binding constants is
identical in either instance.
In the present study, the amount of IgG bound to immobilized
THP was estimated by comparing the 0D410 of these samples to
that of wells in which IgG had been bound to the plastic
substrate. In these calculations, it was assumed that all of the
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Fig. 6. Scatchard plot of sTHP/sheep IgG ELJSA binding data from
ewe E-2. Dotted line represents the least-squares best fit to the two-site
modelwith KdI = 3.2 x 10"M, Kd, = 8.2 x 10 M, A1 = 6.0 x
M, and A, 4.0 X 10-13 M.
IgG incubated in the "IgG standard" wells had become immo-
bilized on the plastic. Preliminary experiments suggest that the
fraction of IgG adsorbed in these wells was closer to 75%.
However, Kd values calculated from the ELISA were insensi-
tive to variation in the estimate of the absolute amount of IgG
bound. For instance, if instead of assuming that 100% of the IgG
bound to the plastic in the "lgG standard" wells, it was
assumed that only 0.1% bound, then the calculated values of Kd
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Fig. 5. sTHP/sheep IgG ELISA binding data (± s) for ewe E-2. sTHP
from each animal was bound to microtiter plates (1.5 tg/well). After
incubating wells with 3 mg/ml to I g/ml sheep IgG, the amount of IgG
bound to sTHP was quantified using rabbit anti-sheep IgG conjugated to
alkaline phosphatase and subsequently detected with p-nitrophenol
phosphate.
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Fig. 7. ELISA data demonstrating ability of soluble sTHP (30 g/ml)
to inhibit binding of added sheep IgG to immobilized sTHP. Symbols
are: (•) no soluble sTHP; (•) 30 jig/mI sTHP. "No soluble sTHP"
denotes the standard ELISA technique with no soluble sTHP added
during the sheep IgG incubation step. Absorbance at 410 nm SE for 1
mg/ml to 5 jig/mI sheep IgG samples.
for the high and low affinity sites remained virtually unchanged
while the number of predicted binding sites, A1 and A2,
decreased by a factor of 1000.
Previous studies demonstrating high affinity binding between
immobilized TNF and soluble THP [15], and between immobi-
lized IL-i and soluble THP [13, 461 were questioned by
Moonen, Gaffner and Wingfield [47], who suggested that these
observations might be due to the binding of THP to denatured
cytokines rather than THP having a true affinity for native
cytokines. This apparently was not the case for the sTHP/sheep
IgG interaction because soluble sTHP could inhibit this binding
(Fig. 7).
The binding between hTHP and human IgG was significant in
establishing that THP/IgG binding was not unique to sheep. The
affinity binding constants of the one male hTHP sample tested
was similar to the binding constants of sTHP. Much work
remains in characterizing individual, sex, and species variations
in THP/IgG binding affinities. Also, the ability of THP to bind
the various subclasses of IgG and other classes of immunoglob-
ulins (Ig) needs to be explored. Furthermore, the site on IgG
involved in binding THP needs to be determined. It is possible
that THP binds the IgG light chain since the ability of THP to
aggregate with some Bence Jones proteins under variable ionic
conditions has been documented [48—50]. However, the asso-
ciation of THP with Bence Jones protein occurred at NaCI
concentrations [49] that typically aggregate THP alone [51, 52].
In light of this newly described ability of THP to bind IgG,
re-evaluation of several previous studies which had yielded
some puzzling results now produces some interesting hypothe-
ses. For instance, B cells can be stimulated to proliferate and
increase immunoglobulin production by some, but not all,
hTHP preparations [19, 20]. Since THP binds IgG, perhaps B
cells were stimulated by THP binding to surface Ig on these
cells. Data from Hunt et al [20] demonstrated a correlation
between the presence of a high molecular weight protein in
hTHP samples and the sample's inability to stimulate B cells. If
this high molecular weight protein was IgG, then in hTHP
samples containing this contaminant, the THP/immunoglobulin
binding sites would be occupied, greatly decreasing any poten-
tial interaction between THP and B cell surface 1g.
Besides the interaction of THP with B cells, experiments
evaluating the interaction of PMN with hTHP warrant further
examination. Kuriyama and Silverblatt [53] reported that the
normal phagocytosis by PMN of nonopsonized, type 1 fimbri-
ated E. coli was inhibited if hTHP was preincubated with these
bacteria, presumably because hTHP and PMN competed for
the same E. coli receptors. However, when 5% serum was
added to the PMN/hTHP/E. coilsystem, PMN ingested E. coil.
In a seemingly contradictory study, Horton et al [23] demon-
strated PMN degranulation, respiratory burst, and leukotriene
B4 release initiated by particulate hTHP,
The differences in these two studies might be resolved by
considering the possible contamination of the hTHP samples
with human IgG. PMN have Fc receptors for IgG that, when
occupied, produce the activation response [54] seen by Horton
et al [23] upon THP addition. IgG bound to THP likely still has
at least a portion of its Fc region available for binding to other
proteins, as suggested in the present study, where protein G,
which binds the Fc fragment [55, 56], appeared to recognize
THP-IgG complexes (Fig. 3C). Therefore, a hTHP/human IgG
complex may bind to PMN Fc receptors, thus explaining the
findings of Horton et al [23]. Similar reasoning that THP
samples were slightly contaminated with IgG could partially
explain the results of Yu et al [24], who recently demonstrated
that THP increased PMN phagocytosis and appeared to adhere
to PMN cell surface. Additionally, if Kuriyama and Silver-
blatt's [53] hTHP samples were initially free of IgG, it is
possible that no activation of PMN by hTHP coated E. co/i
would result until serum (with IgG) was added to the system.
While THP previously has been speculated to play a role in
immunoregulation and in the immune defenses of the urinary
tract [57], a definitive immunologic function has not been
proven. The observation of high affinity binding between IgG
and THP strengthens these previous suspicions. As research
continues into the interaction between THP, immune cells, and
pathogens, the significance of immunoglobulins in these inter-
actions requires attention.
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